Residents’ Corner

Miscommunication With Dermatology Patients: Are We Speaking the Same Language?

Author and Disclosure Information

 

References

Trade Names

In dermatology, we often use trade names to refer to our medications, even if we do not intend to reference the brand name of the drug specifically. We may tell a patient to use Lidex (Medicis Pharmaceutical Corporation) for her hands but then send an escript to her pharmacy for fluocinonide. Trade names are designed to roll off the tongue, in contrast to the unwieldy, clumsily long generic names assigned to many of our medications.

Substituting trade names may facilitate more natural conversation to promote patient understanding in some cases; however, there are pitfalls associated with this habit. First, we may be doing our patients a disservice if we do not clarify when it would be acceptable to substitute with the generic when the medication is available over-the-counter. If we decide to treat with Rogaine (Johnson & Johnson Consumer Inc) but do not suggest the option of purchasing the generic minoxidil, the patient could be unnecessarily overpaying for a brand name by following our instructions.

Conversely, there are scenarios in which the use of a brand name is actually not specific enough. A patient once told me she was using Differin (Galderma Laboratories, LP) as discussed at her prior visit, but she revealed she was washing it off after application. I initially assumed she misunderstood that adapalene was a gel to be applied and left on. After additional questioning, however, it became clear that she purchased the Differin gentle cleanser, a nonmedicated facial wash, rather than the retinoid we had intended for her. I had not considered that Differin would market an entire line of skin care products but now realize we must be cautious using Differin and adapalene interchangeably. Other examples include popular over-the-counter antihistamine brands such as Allegra (Chattem, a Sanofi company) or Benadryl (Johnson & Johnson Consumer Inc) that market multiple products with different active ingredients.

Final Thoughts

The smooth transfer of information between physician and patient is key to a healthy therapeutic relationship. In residency and throughout our careers, we will continue to develop and refine our communication skills to best serve our patients. We should pay particular attention to the unexpected and surprising ways in which we fail to adequately communicate, make note of these patterns, and share with our colleagues so that we can all learn from our collective experiences.

Pages

Recommended Reading

Useful financial and efficiency advice to practices is hard to come by
MDedge Dermatology
Drug-pricing policies find new momentum as ‘a 2020 thing’
MDedge Dermatology
Anxiety, depression, burnout higher in physician mothers caring for others at home
MDedge Dermatology
Medical ethics and economics
MDedge Dermatology
Shifting drugs from Part B to Part D could be costly to patients
MDedge Dermatology
Winners and losers under bold Trump plan to slash drug rebate deals
MDedge Dermatology
President Trump calls for end to HIV/AIDS, pediatric cancer
MDedge Dermatology
Hearing drills into patient impact of ACA legal challenge
MDedge Dermatology
Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
MDedge Dermatology
Terminating an employee
MDedge Dermatology